Carlos Alonso is corporate vice president and president of Baxter's Latin America region. The regional operations consist of 19 countries, five manufacturing facilities, and a product portfolio representing all of Baxter's Renal, Medication Delivery and BioScience businesses.
Alonso joined Baxter in August 1996 as a business unit director in Spain. In 2000, he became vice president of Baxter's BioScience business for Asia, Australia, Latin America, New Zealand and Turkey. He was named general manager of Baxter Argentina in 2001, and was appointed vice president of Renal in Canada in 2003. In 2004, he was named general manager of Baxter Brazil and soon after added oversight of Argentina and Chile to his responsibilities. In September 2006, Alonso was promoted to president, Latin America.
Prior to joining Baxter, Alonso was Country Manager for Dentsply in Spain and Portugal for five years. He also previously held management roles at several Spain- and Brazil-based companies, including Leybold-Heraeus, Espec and Oxiteno.
Alonso is a member of the University of Miami's School of Business Advisory Board.
Alonso is a graduate of Brazil's Universidade Federal do Paraná in Curitiba where he earned his degree in chemical engineering. In addition, he has a master's degree in chemical process automation from the Instituto Quimico de Sarriá in Barcelona, Spain and a master's degree in management from IESE-Universidad de Navarra, also in Barcelona, Spain.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Print this page
